Ischemic Versus Bleeding Outcomes After Percutaneous Coronary Interventions in Patients With High Bleeding Risk-Reference-Cited by-同舟云学术

Ischemic Versus Bleeding Outcomes After Percutaneous Coronary Interventions in Patients With High Bleeding Risk

Published:2020-06 Issue:11 Volume:125 Page:1631-1637
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Gajanana Deepakraj,Rogers Toby^ORCID,Weintraub William S.,Kolm Paul^ORCID,Iantorno Micaela,Khalid Nauman,Chen Yuefeng^ORCID,Shlofmitz Evan^ORCID,Khan Jaffar M.,Musallam Anees,Ben-Dor Itsik,Satler Lowell F.,Zhang Cheng,Torguson Rebecca,Waksman Ron^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European;Kastrati;Eur Heart J,2017

2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

3. Antithrombotic therapy for patients with STEMI undergoing primary PCI;Franchi;Nat Rev Cardiol,2017

4. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N Engl J Med,2014

5. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk;Journal of the American College of Cardiology;2022-09

2. Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project;Frontiers in Cardiovascular Medicine;2022-03-23

3. Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction;Clinical and Applied Thrombosis/Hemostasis;2022-01

4. The efficacy and safety of the short‐term combination therapy with ticagrelor and PPIs or H2RA in patients with acute STEMI who underwent emergency PCI;Clinical and Translational Science;2021-10-20

5. P2Y12 Inhibitor Monotherapy Versus Conventional Dual Antiplatelet Therapy or Aspirin Monotherapy in Acute Coronary Syndrome: A Pooled Analysis of the SMART-DATE and SMART-CHOICE Trials;The American Journal of Cardiology;2021-07